Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer

Although multigene panel testing is increasingly common in patients with cancer, the relationship between its use among breast cancer patients with non‐BRCA mutations or variants of uncertain significance (VUS) and disease management decisions has not been well described. This study evaluated the ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsayegh, Nisreen, Webster, Rachel D., Gutierrez Barrera, Angelica M., Lin, Heather, Kuerer, Henry M., Litton, Jennifer K., Bedrosian, Isabelle, Arun, Banu K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010764/
https://www.ncbi.nlm.nih.gov/pubmed/29733510
http://dx.doi.org/10.1002/cam4.1519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010764/
https://www.ncbi.nlm.nih.gov/pubmed/29733510
http://dx.doi.org/10.1002/cam4.1519

Ejemplares similares